Curcumin Ameliorates Streptozotocin-Induced Heart Injury in Rats

Journal of Biochemical and Molecular Toxicology

Volumn 28, Issue 6, 2014, Pages 263-270

  Abo Salem, Osama M ^a,b   Harisa, Gamaleldin I ^b,c   Ali, Tarek M ^a,d   El Sayed, El Sayed M ^b   Abou Elnour, Fatma M ^e  

^a TAIF UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d BENI SUEF UNIVERSITY   (Egypt)

^e MINISTRY OF HEALTH   (Saudi Arabia)

Author keywords

Curcumin; Cytokines; Diabetes; Heart Injury; Oxidative Stress; STZ

Indexed keywords

CATALASE; CURCUMIN; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT; AUTACOID; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EXPERIMENTAL HEART FAILURE; GLUCOSE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; STREPTOZOTOCIN INDUCED HEART FAILURE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; HEART FAILURE; HEART MUSCLE; METABOLISM; ORGAN SIZE; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; GLYBURIDE; HEART FAILURE; INFLAMMATION MEDIATORS; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIUM; NITRIC OXIDE; ORGAN SIZE; OXIDATIVE STRESS; RATS, WISTAR; STREPTOZOCIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902249269     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21562     Document Type: Article

References (52)

1. Trost S, LeWinter M. Diabetic cardiomyopathy. Curr Treat Options Cardiovasc Med 2001;3:481-492.
2. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115:3213-3223.
3. Fisman EZ, Motro M, Tenenbaum A. Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2003;2:11-16.
4. Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology 2006;147:5967-5974.
5. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 2006;98:596-605.
6. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 2004;44:97-111.
7. Deng SL, Chen WF, Yang BZL, Liu ZL. Protective effects of curcumin and its analogues against free radical-induced oxidative haemolysis of human red blood cells. Food Chem 2006;98:112-119.
8. Baliga MS, Katiyar SK. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci 2006;5:243-253.
9. Suryanarayana P, Krishnaswamy K, Reddy GB. Effect of curcumin on galactose-induced cataractogenesis in rats. Mol Vis 2003;9:223-230.
10. Mukhopadhyay A, Basu N, Ghatak N, Gujral PK. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions 1982;12:508-515.
11. Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997;166:169-175.
12. Kuroda M, Mimaki Y, Nishiyama T, Mae T, Kishida H, Tsukagawa M, Takahashi K, Kawada T, Nakagawa K, Kitahara M. Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 2005;28:937-939.
13. Jain SK, Rains J, Jones K. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med 2006;41:92-96.
14. Sekar N, Kanthasamy A, William S, Subramanian S, Govindasamy S. Insulinic actions of vanadate in diabetic rats. Pharmacol Res 1990;22:207-217.
15. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J. Antioxidant defense system in diabetic kidney: a time course study. Life Sci 1997;60:667-679.
16. Nazam AM, Bhandari U, Pillai KK. Protective role of curcumin in myocardial oxidative damage induced by isoproterenol in rats. Hum Exp Toxicol 2007;26:933-938.
17. Kapoor P, Ansari MN, Bhandari U. Modulatory effect of curcumin on methionine-induced hyperlipidemia and hyperhomocysteinemia in albino rats. Indian J Exp Biol 2008;46:534-540.
18. Ramesh B, Pugalendi KV. Influence of umbelliferone on membrane-bound ATPases in streptozotocin-induced diabetic rats. Pharmacol Rep 2007;59:339-348.
19. Bruce AJ, Baudry M. Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic Biol Med 1995;18:993-1002.
20. Diniz YS, Rocha KK, Souza GA, Galhardi CM, Ebaid GM, Rodrigues HG, Novelli Filho JL, Cicogna AC, Novelli EL. Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur J Pharmacol 2006;543:151-157.
21. Lum G, Gambino SR. A comparison of serum versus heparinized plasma for routine chemistry tests. Am J Clin Pathol 1974;61:108-113.
22. Hortelano S, Dewez B, Genaro AM, az-Guerra MJ, Bosca L. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 1995;21:776-786.
23. Abrams JS. Immunoenzymatic assay of cytokines using NIP-labeled antibodies. In: Coligan J, Kruisbeck A, Margulies D, Shevach E, Strober W, editors. Current protocols in immunology. New York: Wiley; 1995. pp 620-642.
24. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-278.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
26. Ellman M. A spectrophotometric method for determination of reduced glutathione in tissues. Anal Biochem 1959;74:214-226.
27. Aebi HE. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1983. Vol 3, pp 276-286.
28. Marklund SL. Pyrogallol autooxidation. In: Greenwald RA, editor. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press; 1985. pp 243-247.
29. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
30. Banchroft JD, Stevens A, Tumer DR. Theory and practice of histological techniques, 4th edition. New York: Churchill Livingstone 1996. pp 117-123.
31. Ustinova EE, Barrett CJ, Sun SY, Schultz HD. Oxidative stress impairs cardiac chemoreflexes in diabetic rats. Am J Physiol Heart Circ Physiol 2000;279:2176-2187.
32. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003;26:1589-1596.
33. Da Ros R, Assaloni R, Ceriello A. Antioxidant therapy in diabetic complications: what is new? Curr Vasc Pharmacol 2004;2:335-341.
34. Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001;1:181-193.
35. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte at the transcriptional level hypertrophy in diabetes. Am J Physiol Endocrinol Metab 2008;294:1119-1126.
36. Maritim AC, Sanders RA, Watkins A. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003;17(1):24-38.
37. Suryanarayana P, Satyanarayana A, Balakrishna N, Kumar PU, Reddy GB. Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Med Sci Monit 2007;13:286-292.
38. Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM. Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic isturbances and renal oxidative parameters. Pak J Pharm Sci 2009;22(2):205-210.
39. El-Sayed EM, Abo-Salem OM, Aly HA, Mansour AM. Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats. Pak J Pharm Sci 2009;22(2):168-174.
40. Davi G, Falco A, Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005;7:256-268.
41. Lyons T. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes. Diabet Med 1991;8:411-419.
42. Song Y, Wang J, Li Y, Du Y, Arteel GE, Saari JT, Kang YJ, Cai L. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am J Pathol 2005;167:17-26.
43. Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1995;11:551-554.
44. Kaul N, Siveski-Iliskovic N, Hill M, Khaper N, Seneviratne C, Singal PK. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem 1996;161:283-288.
45. Stefek M, Sotnikova R, Okruhlicova L, Volkovova K, Kucharska J, Gajdosik A, Gajdosikova A, Mihalova D, Hozova R, Tribulova N, Gvozdjakova A. Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol 2000;37:111-117.
46. Sanders RA, Rauscher FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001;15:143-149.
47. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S. Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab 2006;3:27-32.
48. Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995;206:533-540.
49. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700-713.
50. Drimal J, Knez V, Navarova J, Nedelcevova J, Paulovicova E, Sotnikova R, Snirc V, Drimal D. Role of inflammatory cytokines and chemoatractants in the rat model of streptozotocin-induced heart failure. Endocr Regul 2008;42:129-135.
51. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J Immunol 1996;157:1630-1637.
52. Lin JK. Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch Pharm Res 2004;27:683-692.